3215 Reducing anticholinergic burden (ACB) within the healthcare for older people's (HCOP) wards

IF 6 2区 医学 Q1 GERIATRICS & GERONTOLOGY
K Ng, N Tan
{"title":"3215 Reducing anticholinergic burden (ACB) within the healthcare for older people's (HCOP) wards","authors":"K Ng, N Tan","doi":"10.1093/ageing/afaf133.052","DOIUrl":null,"url":null,"abstract":"Introduction Medications with anticholinergic properties can have significant adverse effects, particularly in older adults. An Anticholinergic Burden (ACB) score of ≥3 is associated with increased risks of falls, cognitive impairment, and mortality. Additionally, side effects such as urinary retention, visual disturbances, and constipation are frequent contributors to delirium. Aim To assess whether raising awareness of ACB within the Healthcare of Older People (HCOP) department can lead to a reduction in ACB scores. Methods Over four months, a teaching session and a poster was disseminated on ACB. Retrospective data were collected from three separate weeks, one before any intervention, one after the teaching session and one after the poster for patients discharged from the HCOP department. Admission and discharge ACB scores were calculated using the ACB Calculator (www.acbcalc.com). Patients on end-of-life medications were excluded. Results Cycle 1: Of 40 patients, 13 had an ACB score ≥ 3 on discharge. Seven patients retained their admission ACB scores ≥3 at discharge, while eight patients showed a reduction. A lack of awareness of ACB was identified, prompting a teaching session. Cycle 2: Of 33 patients, eight had an ACB score ≥ 3 on discharge, and 11 showed a reduction in scores. A poster campaign was launched across HCOP doctors’ offices. Cycle 3: Among 39 patients, 17 had an ACB score ≥ 3 on discharge. However, this cycle achieved the highest number of score reductions, with 12 patients showing improvement. A side analysis revealed that lansoprazole was the most commonly prescribed medication with anticholinergic properties, affecting 33 patients across the three cycles. Conclusion Raising awareness of ACB scores has successfully reduced ACB scores. Sustained efforts, including regular reminders and medication reviews, are essential to mitigate risks for older patients. Ongoing discussions with the pharmacy team aim to implement an automated ACB score calculation in the online noting system.","PeriodicalId":7682,"journal":{"name":"Age and ageing","volume":"20 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Age and ageing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ageing/afaf133.052","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction Medications with anticholinergic properties can have significant adverse effects, particularly in older adults. An Anticholinergic Burden (ACB) score of ≥3 is associated with increased risks of falls, cognitive impairment, and mortality. Additionally, side effects such as urinary retention, visual disturbances, and constipation are frequent contributors to delirium. Aim To assess whether raising awareness of ACB within the Healthcare of Older People (HCOP) department can lead to a reduction in ACB scores. Methods Over four months, a teaching session and a poster was disseminated on ACB. Retrospective data were collected from three separate weeks, one before any intervention, one after the teaching session and one after the poster for patients discharged from the HCOP department. Admission and discharge ACB scores were calculated using the ACB Calculator (www.acbcalc.com). Patients on end-of-life medications were excluded. Results Cycle 1: Of 40 patients, 13 had an ACB score ≥ 3 on discharge. Seven patients retained their admission ACB scores ≥3 at discharge, while eight patients showed a reduction. A lack of awareness of ACB was identified, prompting a teaching session. Cycle 2: Of 33 patients, eight had an ACB score ≥ 3 on discharge, and 11 showed a reduction in scores. A poster campaign was launched across HCOP doctors’ offices. Cycle 3: Among 39 patients, 17 had an ACB score ≥ 3 on discharge. However, this cycle achieved the highest number of score reductions, with 12 patients showing improvement. A side analysis revealed that lansoprazole was the most commonly prescribed medication with anticholinergic properties, affecting 33 patients across the three cycles. Conclusion Raising awareness of ACB scores has successfully reduced ACB scores. Sustained efforts, including regular reminders and medication reviews, are essential to mitigate risks for older patients. Ongoing discussions with the pharmacy team aim to implement an automated ACB score calculation in the online noting system.
3215减少老年人保健病房的抗胆碱能负担(ACB)
具有抗胆碱能特性的药物可能有明显的副作用,特别是对老年人。抗胆碱能负荷(ACB)评分≥3与跌倒、认知障碍和死亡风险增加相关。此外,尿潴留、视力障碍和便秘等副作用也是谵妄的常见原因。目的评估提高老年人医疗保健(HCOP)部门对ACB的认识是否会导致ACB评分的降低。方法进行为期4个月的ACB教学,并张贴海报。回顾性数据从三个不同的星期收集,一个是在任何干预之前,一个是在教学课程之后,一个是在HCOP部门出院患者的海报之后。使用ACB计算器(www.acbcalc.com)计算入院和出院ACB评分。接受临终药物治疗的患者被排除在外。第1周期:40例患者中,13例出院时ACB评分≥3分。7例患者出院时ACB评分≥3分,8例患者评分降低。发现了对ACB缺乏认识,促使进行了一次教学。周期2:33例患者中,8例出院时ACB评分≥3分,11例评分降低。一项海报活动在HCOP医生办公室展开。周期3:39例患者中,17例出院时ACB评分≥3。然而,这个周期取得了最多的分数下降,有12名患者表现出改善。一项侧面分析显示,兰索拉唑是最常用的抗胆碱能药物,在三个周期中影响了33名患者。结论提高ACB评分意识,有效降低了ACB评分。持续的努力,包括定期提醒和药物审查,对于减轻老年患者的风险至关重要。正在与药房团队讨论的目标是在在线记录系统中实现自动ACB分数计算。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Age and ageing
Age and ageing 医学-老年医学
CiteScore
9.20
自引率
6.00%
发文量
796
审稿时长
4-8 weeks
期刊介绍: Age and Ageing is an international journal publishing refereed original articles and commissioned reviews on geriatric medicine and gerontology. Its range includes research on ageing and clinical, epidemiological, and psychological aspects of later life.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信